RENAPIME

This brand name is authorized in Estonia, United Kingdom

Active ingredients

The drug RENAPIME contains one active pharmaceutical ingredient (API):

1 Cefepime UNII I8X1O0607P - CEFEPIME HYDROCHLORIDE

Cefepime is a broad-spectrum, bactericidal antibiotic, with activity against a wide range of Gram-positive and Gram-negative bacteria, including many strains resistant to aminoglycosides or third generation cephalosporins. It has a reduced affinity for beta-lactamases. Read about Cefepime

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
RENAPIME Powder for solution for injection / infusion	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01DE01	Cefepime	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DE Fourth-generation cephalosporins
Discover more medicines within J01DE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1825286
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 364569, 364572